AKCEA-APO(a)-LRx

AKCEA-APO(a)-LRx Uses, Dosage, Side Effects, Food Interaction and all others data.

AKCEA-APO(a)-LRx is under investigation in clinical trial NCT03070782 (Phase 2 Study of ISIS 681257 (Akcea-apo(a)-lrx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease).

Trade Name AKCEA-APO(a)-LRx
Generic Pelacarsen
Pelacarsen Other Names AKCEA-APO(a)-LRx, IONIS-APO(a)-LRx, Isis-681257 (galnac3--conjugated aso targeting human lipoprotein (a)) free acid, Pelacarsen
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
AKCEA-APO(a)-LRx
AKCEA-APO(a)-LRx

Innovators Monograph

You find simplified version here AKCEA-APO(a)-LRx


*** Taking medicines without doctor's advice can cause long-term problems.
Share